Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 1 | $24,987 |
| Sells | 10 | $25,680,840 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 15 Aug 2024 17:06 | KROS | Keros Therapeutics Inc | GORDON CARL L | Director | 13 Aug 2024 | Sale | 29,400 | 44.01 | 1,293,894 | I |
| 15 Aug 2024 17:06 | KROS | Keros Therapeutics Inc | GORDON CARL L | Director | 13 Aug 2024 | Sale | 220,600 | 44.01 | 9,708,606 | I |
| 15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 29,400 | 44.01 | 1,293,894 | I |
| 15 Aug 2024 17:01 | KROS | Keros Therapeutics Inc | ORBIMED ADVISORS LLC | Director | 13 Aug 2024 | Sale | 220,600 | 44.01 | 9,708,606 | I |
| 08 Jan 2024 16:43 | KROS | Keros Therapeutics Inc | REGNANTE KEITH | Chief Financial Officer | 04 Nov 2023 | Sale | 40,000 | 45.29 | 1,811,600 | D |
| 12 Jun 2023 16:13 | KROS | Keros Therapeutics Inc | REGNANTE KEITH | Chief Financial Officer | 09 Jun 2023 | Sale | 2,579 | 47.25 | 121,858 | D |
| 12 Jun 2023 16:13 | KROS | Keros Therapeutics Inc | REGNANTE KEITH | Chief Financial Officer | 09 Jun 2023 | Sale | 1,428 | 46.46 | 66,345 | D |
| 12 Jun 2023 16:13 | KROS | Keros Therapeutics Inc | REGNANTE KEITH | Chief Financial Officer | 09 Jun 2023 | Sale | 15,993 | 45.03 | 720,165 | D |
| 12 Jun 2023 16:13 | KROS | Keros Therapeutics Inc | REGNANTE KEITH | Chief Financial Officer | 08 Jun 2023 | Sale | 2,699 | 48.65 | 131,306 | D |
| 12 Jun 2023 16:13 | KROS | Keros Therapeutics Inc | REGNANTE KEITH | Chief Financial Officer | 08 Jun 2023 | Sale | 17,301 | 47.66 | 824,566 | D |
| 20 Jan 2023 16:32 | KROS | Keros Therapeutics Inc | KNOWLES JULIUS | Director | 13 Apr 2020 | Purchase | 1,191 | 20.98 | 24,987 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)